KRX Bio Technology Transfer Index

The index holds up to 15 bio-pharmaceutical stocks listed on the KOSPI or KOSDAQ, selected by cumulative technology transfer deal value disclosed within the most recent 60 months. The universe requires AICS primary classification in Pharmaceutical Manufacturing [3254], Medical Equipment [3391], or Scientific R&D Services [5417], with minimum market capitalization of KRW 300 billion and 3-month average daily trading value of KRW 1 billion. A buffer rule retains existing constituents whose composite score (technology transfer value + free-float market cap) ranks within the top 12, and a floor of 10 constituents is maintained by adding the largest remaining stocks if needed. Weights blend 50% free-float market cap and 50% technology transfer value, capped at 15% per stock, and the index is rebalanced quarterly.